Mild Persistent Asthma Care App Asthma is a chronic inflammatory disease of the airways. In the United States, asthma affects more than 22 million persons. It is one of the most common chronic diseases of childhood, affecting more than 6 million children.
This app gives patients who are have mild persistent asthma:
Impairment and risk patient reported outcome surveys
Apple Care Card to track inhaled glucocorticoid use
Patient education content library
Notifications to answer clinically important questions
Integrations with gold standard activity tracker (ie Apple Healthkit)
This App applies Evidence Based Medicine to improve patient care through digital technology . It also gives patients easy access to information from reputable sources including the NIH, Asthma and Allergy Foundation of America, American Lung Association, and American Academy of Allergy, Asthma & Immunology .
National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma
Long-term, once-daily treatment with low-dose budesonide decreases the risk of severe exacerbations and improves asthma control in patients with mild persistent asthma of recent onset. This intervention is reflected in this app.